Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Integra Lifesciences Holdings (IART) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Integra Lifesciences Holdings (IART) over the last 16 years, with Q3 2025 value amounting to 0.45.

  • Integra Lifesciences Holdings' Asset Utilization Ratio rose 1684.24% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 1684.24%. This contributed to the annual value of 0.41 for FY2024, which is 250.0% up from last year.
  • Per Integra Lifesciences Holdings' latest filing, its Asset Utilization Ratio stood at 0.45 for Q3 2025, which was up 1684.24% from 0.42 recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Asset Utilization Ratio registered a high of 0.45 during Q3 2025, and its lowest value of 0.37 during Q1 2021.
  • In the last 5 years, Integra Lifesciences Holdings' Asset Utilization Ratio had a median value of 0.41 in 2021 and averaged 0.41.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Asset Utilization Ratio plummeted by 1640.23% in 2021 and then skyrocketed by 1684.24% in 2025.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Asset Utilization Ratio stood at 0.41 in 2021, then decreased by 0.85% to 0.4 in 2022, then rose by 1.27% to 0.41 in 2023, then fell by 3.03% to 0.4 in 2024, then grew by 13.02% to 0.45 in 2025.
  • Its last three reported values are 0.45 in Q3 2025, 0.42 for Q2 2025, and 0.4 during Q1 2025.